Want to see HK:6998 full AI Analyst Report?
Total Valuation
Genor Biopharma Holdings Limited has a market cap or net worth of HK$3.42B. The enterprise value is HK$3.62B.
Market CapHK$3.42B
Enterprise ValueHK$3.62B
Share Statistics
Genor Biopharma Holdings Limited has 2,014,126,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,014,126,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genor Biopharma Holdings Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 10.13%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)10.13%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee1.80M
Profits Per Employee331.06K
Employee Count1,499
Asset Turnover0.41
Inventory Turnover2.17
Valuation Ratios
The current PE Ratio of Genor Biopharma Holdings Limited is 4.7. Genor Biopharma Holdings Limited’s PEG ratio is -0.16.
PE Ratio4.7
PS Ratio1.67
PB Ratio1.17
Price to FCF11.17
Price to Operating Cash Flow4.83
PEG Ratio-0.16
Income Statement
In the last 12 months, Genor Biopharma Holdings Limited had revenue of 2.70B and earned 433.01M in profits. Earnings per share was 0.23.
Revenue2.70B
Gross Profit1.76B
Operating Income689.46M
Pretax Income538.21M
Net Income433.01M
EBITDA933.65M
Earnings Per Share (EPS)0.23
Cash Flow
In the last 12 months, operating cash flow was 600.32M and capital expenditures -53.81M, giving a free cash flow of 546.51M billion.
Operating Cash Flow600.32M
Free Cash Flow546.51M
Free Cash Flow per Share0.27
Dividends & Yields
Genor Biopharma Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change-55.26%
50-Day Moving Average1.66
200-Day Moving Average2.30
Relative Strength Index (RSI)51.55
Average Volume (3m)1.06M
Important Dates
Genor Biopharma Holdings Limited upcoming earnings date is Mar 31, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateMar 31, 2027
Ex-Dividend Date―
Financial Position
Genor Biopharma Holdings Limited as a current ratio of 1.00, with Debt / Equity ratio of 29.71%
Current Ratio1.00
Quick Ratio0.80
Debt to Market Cap0.32
Net Debt to EBITDA0.46
Interest Coverage Ratio3.86
Taxes
In the past 12 months, Genor Biopharma Holdings Limited has paid 105.20M in taxes.
Income Tax105.20M
Effective Tax Rate0.20
Enterprise Valuation
Genor Biopharma Holdings Limited EV to EBITDA ratio is 5.29, with an EV/FCF ratio of 12.23.
EV to Sales1.83
EV to EBITDA5.29
EV to Free Cash Flow12.23
EV to Operating Cash Flow10.94
Balance Sheet
Genor Biopharma Holdings Limited has HK$913.17M in cash and marketable securities with HK$1.18B in debt, giving a net cash position of -HK$269.05M billion.
Cash & Marketable SecuritiesHK$913.17M
Total DebtHK$1.18B
Net Cash-HK$269.05M
Net Cash Per Share-HK$0.13
Tangible Book Value Per ShareHK$0.13
Margins
Gross margin is 62.60%, with operating margin of 25.56%, and net profit margin of 16.05%.
Gross Margin62.60%
Operating Margin25.56%
Pretax Margin19.95%
Net Profit Margin16.05%
EBITDA Margin34.61%
EBIT Margin25.56%
Analyst Forecast
The average price target for Genor Biopharma Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1417.68%
EPS Growth Forecast660.14%